Clinical effect of treatment on elderly chronic obstructive pulmonary disease combined with pulmonary tuberculosis.
To explore and analyze the clinical therapeutic schedule of elderly chronic obstructive pulmonary disease combined with pulmonary tuberculosis. This clinical research analysis chooses the 2000 patients suffered elderly chronic obstructive pulmonary disease combined with pulmonary tuberculosis treated in the hospital during June of 2014 and June of 2015 as the object of observation. These 2000 cases are randomly divided into experimental group and control group. The patients in the control group are treated with the common method; based on the common method, those in the experimental group are treated with the atomization inhalation treatment of compound ipratropium bromide and budesonide and have rifampicin. The clinical effects of two groups are observed and contracted. The clinical treatment, CRP and other clinical evaluation indexes of experimental group are superior to the control group (P<0.05). There are significant differences between two groups with the statistical significance. The atomization inhalation treatment of compound ipratropium bromide and budesonide and rifampicin are implied into the elderly chronic obstructive pulmonary disease combined with pulmonary tuberculosis that can remarkably improve the effect of clinical treatment has higher clinical promotional value.